Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 15, 2015Molecular OncologyOpen Access

High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti‐HER2 therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

PNPaolo NucíforoHebron UniversitySTSheeno ThyparambilDartmouth–Hitchcock Medical CenterCAClaudia AuraInstitut Català d'Oncologia

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nuciforo et al. (2015) studied this question.

synapsesocial.com/papers/6ab5cd334284cf0d29195047https://doi.org/10.1016/j.molonc.2015.09.002
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Multiplexed quantification of estrogen receptor and HER 2/ N eu in tissue and cell lysates by peptide immunoaffinity enrichment mass spectrometry2012 · 51 citations
  2. 2American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer2006 · 4,474 citations
  3. 3Human Epidermal Growth Factor Receptor 2 Testing in Primary Breast Cancer in the Era of Standardized Testing: A Canadian Prospective Study2014 · 17 citations
  4. 4Potential biomarkers of long‐term benefit from single‐agent trastuzumab or lapatinib in HER2‐positive metastatic breast cancer2013 · 42 citations
  5. 5Trastuzumab-Induced Hepatotoxicity: A Case Report2013 · 4,416 citations